Literature DB >> 8428579

N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B.

L J van 't Veer1, R L Beijersbergen, R Bernards.   

Abstract

In neuroblastoma, N-myc suppresses the expression of major histocompatibility complex (MHC) Class I antigens by reducing the binding of a nuclear factor to the enhancer-A element in the MHC Class I gene promoter. We show here that the p50 subunit of NF-kappa B is part of this complex and that expression of p50 mRNA is suppressed by N-myc. Transfection of a p50 expression vector in neuroblastoma cells that express N-myc at a high level leads to restoration of factor binding to the MHC Class I gene enhancer, restores enhancer activity and leads to re-expression of MHC Class I antigens at the cell surface. These data indicate that the p50 subunit of NF-kappa B is involved in the regulation of MHC Class I antigen expression and that N-myc down-regulates MHC Class I gene expression primarily through suppression of p50 expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428579      PMCID: PMC413191          DOI: 10.1002/j.1460-2075.1993.tb05645.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

Review 1.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

2.  N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma.

Authors:  R Bernards; S K Dessain; R A Weinberg
Journal:  Cell       Date:  1986-12-05       Impact factor: 41.582

3.  A simple phase-extraction assay for chloramphenicol acyltransferase activity.

Authors:  B Seed; J Y Sheen
Journal:  Gene       Date:  1988-07-30       Impact factor: 3.688

4.  Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter.

Authors:  A S Baldwin; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes.

Authors:  A Israël; A Kimura; M Kieran; O Yano; J Kanellopoulos; O Le Bail; P Kourilsky
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element.

Authors:  J W Pierce; M Lenardo; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  Suppression of MHC class I gene expression by N-myc through enhancer inactivation.

Authors:  M Lenardo; A K Rustgi; A R Schievella; R Bernards
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

9.  The SV40 TC-II(kappa B) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines.

Authors:  M Macchi; J M Bornert; I Davidson; M Kanno; R Rosales; M Vigneron; J H Xiao; C Fromental; P Chambon
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

10.  TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors.

Authors:  A Israël; O Le Bail; D Hatat; J Piette; M Kieran; F Logeat; D Wallach; M Fellous; P Kourilsky
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  18 in total

1.  Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.

Authors:  J H Caamaño; P Perez; S A Lira; R Bravo
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  N-myc over-expression downregulates alpha3beta1 integrin expression in human Saos-2 osteosarcoma cells.

Authors:  R Judware; L A Culp
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

Review 3.  The MYC oncogene is a global regulator of the immune response.

Authors:  Stephanie C Casey; Virginie Baylot; Dean W Felsher
Journal:  Blood       Date:  2018-03-07       Impact factor: 22.113

4.  Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression.

Authors:  Raquel Sitcheran; Pankaj Gupta; Paul B Fisher; Albert S Baldwin
Journal:  EMBO J       Date:  2005-01-20       Impact factor: 11.598

Review 5.  Cancer Immunotherapy: Whence and Whither.

Authors:  Peter J Stambrook; John Maher; Farzin Farzaneh
Journal:  Mol Cancer Res       Date:  2017-03-29       Impact factor: 5.852

6.  Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.

Authors:  L T Peltenburg; P I Schrier
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

7.  Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma.

Authors:  T Maruyama; K Mimura; E Sato; M Watanabe; Y Mizukami; Y Kawaguchi; T Ando; H Kinouchi; H Fujii; K Kono
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

8.  Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma.

Authors:  Takuya Yazawa; Takaaki Ito; Hiroshi Kamma; Takehisa Suzuki; Koji Okudela; Hiroyuki Hayashi; Hisashi Horiguchi; Takesaburo Ogata; Hideaki Mitsui; Masaichi Ikeda; Hitoshi Kitamura
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

9.  Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.

Authors:  L T Peltenburg; R Dee; P I Schrier
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

10.  Inverse expressions of the N-myc oncogene and beta 1 integrin in human neuroblastoma: relationships to disease progression in a nude mouse model system.

Authors:  R Judware; R Lechner; L A Culp
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.